Parametrica Management LTD United Therapeutics Corp Transaction History

Parametrica Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$76.06 - $120.81 $217,379 - $345,274	-2,858 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$107.15 - $126.84 $306,234 - $362,508	2,858 New	2,858 $335,000
Q1 2018 Apr 24, 2018	SELL	$107.21 - $151.94 $387,135 - $548,655	-3,611 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$118.58 - $151.28 $428,192 - $546,272	3,611	3,611 $534,000

562

43.1M

501K

529K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.